Impact of Intravascular Fluid Resuscitation and Whole Blood Viscosity

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

June 30, 2017

Conditions
Cerebral Aneurysm
Interventions
DRUG

Intravenous Crystalloid

crystalloid is administered to maintain stroke volume variation \< 15 during volume controlled ventilation (8 ml/kg tidal volume) of O2/air mixture

DRUG

Intravenous HES

HES is administered to maintain stroke volume variation \< 15 during volume controlled ventilation (8 ml/kg tidal volume) of O2/air mixture

All Listed Sponsors
lead

Konkuk University Medical Center

OTHER

NCT02700607 - Impact of Intravascular Fluid Resuscitation and Whole Blood Viscosity | Biotech Hunter | Biotech Hunter